These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 10338904

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G.
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [Abstract] [Full Text] [Related]

  • 24. Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD.
    Schermer TR, Albers JM, Verblackt HW, Costongs RJ, Westers P.
    Fam Pract; 2007 Apr; 24(2):181-8. PubMed ID: 17251178
    [Abstract] [Full Text] [Related]

  • 25. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary diseases.
    Gupta RK, Chhabra SK.
    Indian J Chest Dis Allied Sci; 2002 Apr; 44(3):165-72. PubMed ID: 12206475
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 30. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.
    Lockey RF, DuBuske LM, Friedman B, Petrocella V, Cox F, Rickard K.
    Chest; 1999 Mar 29; 115(3):666-73. PubMed ID: 10084473
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of inhaled Salmeterol (Serevent) as maintenance therapy for asthma in Nairobi.
    Odhiambo JA, Nganga LW, Gikonyo BM.
    East Afr Med J; 1994 Feb 29; 71(2):88-92. PubMed ID: 7925051
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K, Noonan M, Silkoff PE, Uryniak T.
    Clin Ther; 2007 Jun 29; 29(6):1013-26. PubMed ID: 17692718
    [Abstract] [Full Text] [Related]

  • 36. Extended-release albuterol in the treatment of 6- to 12-year-old asthmatic children.
    Skoner DP, Boltansky H, Kobayashi RH, Pearlman DS, Shapiro G, Harrison JE, Trochelmann LM, Lorber RR.
    Ann Allergy Asthma Immunol; 1996 May 29; 76(5):462-8. PubMed ID: 8630721
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [efficacy and safety of salmeterol in long-term therapy in patients with chronic obstructive airway diseases].
    Beeh KM, Wiewrodt R, Salem AE, Buhl R.
    Pneumologie; 2000 Jun 29; 54(6):225-31. PubMed ID: 10934892
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [The effect of salmeterol in the treatment of smokers with chronic obstructive lung disease].
    Ulrik CS.
    Ugeskr Laeger; 1996 Jun 17; 158(25):3604-7. PubMed ID: 8693619
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.